🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Cancer Female

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Implant-based Breast Reconstruction in Post-bariatric Women - a Registry-based National Study NCT07059104n/a1 site📍 Gothenburg Vastra Gotaland Region · Tests: Breast augmentation, Breast reconstruction after mastectomy A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy NCT06309290NA2 sites📍 Santiago📍 Temuco Universidad de La Frontera · Tests: Prehabilitation with resistance-exercise training, Usual care program Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer NCT06123988NA3 sites📍 Phoenix📍 Miami📍 Boston University of Miami · Tests: Prolonged Overnight Fasting, Moderate-Intensity Exercise, General Health Education Sessions Feasibility of a Lifestyle Intervention for Women With Triple-negative Breast Cancer Under Neoadjuvant Immunotherapy NCT07311083NA1 site📍 Essen Kliniken Essen-Mitte · Tests: switching to a high-fibre diet, official dietary recommendations CONFIRM: Magnetic Resonance Guided Radiation Therapy NCT04368702NA2 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Viewray MRIdian® Linac A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862Phase 116 sites📍 Fountain Valley📍 Jacksonville📍 Orlando Exelixis · Tests: XL309, Olaparib Olaparib+Trastuzumab+Pertuzumab Neoadjuvant for Elderly HER2+ Breast Cancer NCT07695259Phase 41 site📍 Hangzhou Wen-Ming Cao · Tests: olaparib combined with trastuzumab and pertuzumab Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity NCT04273061Phase 22 sites📍 Vancouver📍 Toronto British Columbia Cancer Agency · Tests: Atezolizumab Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer NCT06938724Phase 21 site📍 Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Tests: Omission of local therapies Evaluation of the Effect of Regular Physical Exercise in Breast Cancer. NCT07893327NA1 site📍 San Sebastián de los Reyes Fundación Investigación E Innovación Biomédica Hospital Uni… · Tests: Supervised exercise program Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer NCT07630402NA1 site📍 Rochester University of Rochester · Tests: Echocardiogram A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer NCT07532434n/a1 site📍 Beijing Peking University Third Hospital Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial NCT07158021Phase 21 site📍 Ann Arbor University of Michigan Rogel Cancer Center · Tests: Biospecimen Collection, Electronic Health Record Review, Goserelin, Leuprolide, Questionnaire Administration A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan 18F-FDG PET/CT Imaging for Breast Cancer NCT05730608NA1 site📍 Drammen Vestre Viken Hospital Trust · Tests: 18F-FDG PET/CT SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance NCT07503717NA1 site📍 Beaumont Royal College of Surgeons, Ireland · Tests: Brain Magnetic Resonance Imaging (MRI) with Contrast High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins NCT06835426NA1 site📍 Ghent Algemeen Ziekenhuis Maria Middelares · Tests: Single intravenous injection of the radiotracer, Imaging resected specimen using the high-resolution PET-CT specimen im… A Study of LY4337713 in Participants With FAP-Positive Solid Tumors NCT07213791Phase 130 sites📍 Newport Beach📍 Stanford📍 Miami Eli Lilly and Company · Tests: LY4337713 Genetic Assessment of Breast Cancer Risk in Women in the DORA Programme NCT07734389NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Comprehensive Clinical and Genetic Breast Cancer Risk Assessment A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks NCT07469709n/a1 site📍 Candiolo Fondazione del Piemonte per l'Oncologia Metabolism, Circadian Rhythms and Ovarian Function NCT05007834n/a1 site📍 Lille University Hospital, Lille Alcohol, Breast Cancer, and Metabolism NCT07779967NA1 site📍 Urbana University of Illinois at Urbana-Champaign · Tests: Low-alcohol level exposure, Breast-pumping time ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort NCT07808164n/a2 sites📍 Hanoi📍 Ho Chi Minh City Tam Anh Research Institute · Tests: IHC analysis for ENPP1, cGAS, and FAP expression A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors NCT04895709Phase 1, Phase 247 sites📍 Clovis📍 Los Angeles📍 Newport Beach Bristol-Myers Squibb · Tests: BMS-986340, BMS-936558-01, Docetaxel, Pumitamig
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy